These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30413297)

  • 1. Corrigendum to "Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis" [Biomed. Pharmacother. 106 (2018) 813-820].
    Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
    Biomed Pharmacother; 2019 Mar; 111():1509. PubMed ID: 30413297
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis.
    Wang S; Zuo S; Liu Z; Ji X; Yao Z; Wang X
    Biomed Pharmacother; 2018 Oct; 106():813-820. PubMed ID: 29990875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway" [Biomed. Pharmacother. 84 (2016) 1776-1782].
    Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
    Biomed Pharmacother; 2020 Feb; 122():109782. PubMed ID: 31862132
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to 'Innovated formulation of TCM pangolin scales to develop a nova therapy of rheumatoid arthritis' [Biomed. Pharmacother. 126 (2020) 109872].
    Lv H; Li Z; Xie Z; Hu X; Li H; Sun J; Chen X; Wen C
    Biomed Pharmacother; 2021 Aug; 140():111724. PubMed ID: 34001416
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]" [Biomed. Pharmacother. 152 (2022) 113213].
    Cao L; Wang S; Zhang L; Li J
    Biomed Pharmacother; 2023 Apr; 160():114280. PubMed ID: 36725470
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice" [Biomed. Pharmacother. 110 (2019) 95-104].
    Zhou J; Wu J; Wu CY; Long F; Shen H; Zhang W; Li SL
    Biomed Pharmacother; 2019 Jun; 114():108827. PubMed ID: 30954310
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Comparative study of therapeutic response to baclofen vs tolperisone in spasticity" [Biomed. Pharmacother. 87 (2017) 628-635].
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Aug; 92():1140. PubMed ID: 28623068
    [No Abstract]   [Full Text] [Related]  

  • 8. Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway.
    Yang Y; Ye Y; Qiu Q; Xiao Y; Huang M; Shi M; Liang L; Yang X; Xu H
    Int Immunopharmacol; 2016 Dec; 41():8-16. PubMed ID: 27816728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice" [Biomed. Pharmacother. 118 (2019) 109206].
    Hou Q; Zhu S; Zhang C; Huang Y; Guo Y; Li P; Chen X; Wen Y; Han Q; Liu F
    Biomed Pharmacother; 2019 Oct; 118():109290. PubMed ID: 31471002
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "double sword role of EZH2 in leukemia" [Biomed. Pharmacother. 98 (2018) 626-635].
    Safaei S; Baradaran B; Hagh MF; Alivand MR; Talebi M; Gharibi T; Solali S
    Biomed Pharmacother; 2018 May; 101():786. PubMed ID: 29525673
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A review" [Biomed. Pharmacother. 92 (2017) 681-689].
    Anjum K; Shagufta BI; Abbas SQ; Patel S; Khan I; Shah SAA; Akhter N; Shams-Ul-Hassan S
    Biomed Pharmacother; 2018 May; 101():820. PubMed ID: 29525678
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Dexmedetomidine relieves formaldehyde-induced pain in rats through both α2 adrenoceptor and imidazoline receptor" [Biomed. Pharmacother. 90 (2017) 914-920].
    Zhang H; Yan X; Wang DG; Leng YF; Wan ZH; Liu YQ; Zhang Y
    Biomed Pharmacother; 2017 Dec; 96():1569. PubMed ID: 29153378
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "GJ-4 alleviates Aβ
    Zhang Z; Liu H; Zhao Z; Zang C; Ju C; Li F; Wang L; Yang H; Bao X; Yu Y; Yao X; Zhang D
    Biomed Pharmacother; 2020 Aug; 128():110335. PubMed ID: 32505384
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Luteolin, a flavonoid, as an anticancer agent: A review" [Biomed. Pharmacother. 112 (2019) 108612].
    Imran M; Rauf A; Abu-Izneid T; Nadeem M; Shariati MA; Khan IA; Imran A; Erdogan Orhan I; Rizwan M; Atif M; Aslam Gondal T; Mubarak MS
    Biomed Pharmacother; 2019 Aug; 116():109084. PubMed ID: 31178263
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC" [Biomed. Pharmacother. 110 (2019) 656-666].
    Quan J; Pan X; Li Y; Hu Y; Tao L; Li Z; Zhao L; Wang J; Li H; Lai Y; Zhou L; Lin C; Gui Y; Ye J; Zhang F; Lai Y
    Biomed Pharmacother; 2019 Apr; 112():108755. PubMed ID: 30871752
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Carnitine/organic cation transporter 2 (OCTN2) contributes to rat epididymal epithelial cell growth and proliferation" [Biomed. Pharmacother. 93(2017):444-450].
    Li D; Liu J; Wei D; Liu H; Xiao W; Song X; Fan Z; Ke C; Qiangguo Y; Qin W; Tang Y; Xiaoyong P
    Biomed Pharmacother; 2018 Aug; 104():854. PubMed ID: 29753602
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "LINC00657 played oncogenic roles in esophageal squamous cell carcinoma by targeting miR-615-3p and JunB" [Biomed. Pharmacother. 108 (2018) 316-324].
    Yuchen S; Jizhao W; Shupei P; Tian Y; Xuanzi S; Ya W; Xiaobo S; Xu Z; Jing G; Xiaozhi Z
    Biomed Pharmacother; 2019 Mar; 111():1507. PubMed ID: 30600121
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "miR-142-5p promotes development of colorectal cancer through targeting SDHB and facilitating generation of aerobic glycolysis" [Biomed. Pharmacother. 92 (2017) 1119-1127].
    Liu S; Xiao Z; Ai F; Liu F; Chen X; Cao K; Ren W; Zhang X; Shu P; Zhang D
    Biomed Pharmacother; 2018 Mar; 99():1033-1036. PubMed ID: 29398246
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis" [Biomed. Pharmacother. 97 (330-338) 330-338].
    Srivastava S; Shree P; Pandey H; Tripathi YB
    Biomed Pharmacother; 2018 Nov; 107():1795. PubMed ID: 30115498
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation" [Biomed. Pharmacother. 109 (2018) 2278-2284].
    Zhang Y; Xiang Y; Wang X; Zhu L; Li H; Wang S; Pan X; Zhao H
    Biomed Pharmacother; 2019 Apr; 112():108548. PubMed ID: 30773235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.